Skip to search formSkip to main contentSkip to account menu

DRF 2189

Known as: DRF-2189 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Recent thiazolidinediones as antidiabetics
Thiazolidinediones, a class of oral insulin sensitizing agents that improve insulin resistance, are agonists of peroxisome… 
1999
1999
Indole-containing thiazolidine-2,4-diones as novel euglycemic and hypolipidemic agents: DRF-2189
1999
1999
Oral Bioavailability and Pharmacokinetics of the New lnsulin Sensitizer DRF-2189 in Wistar Rats
Summary The pharmacokinetics of the new insulin sensitizing agent, DRF-2189 ([5-[4-[2-(1-indolyl) ethoxy]phenyl]methyl… 
1999
1999
Studies on the Euglycemic and Hypolipidemic Potentials of the Novel Indole Analogue of Thiazolidinedione, DRF 2189
Summary Euglycemic and hypolipidemic activities of a novel indole analogue of thiazolidinedione, DRF 2189 (CAS 172647-53-9), have… 
1998
1998
High-performance liquid chromatographic determination of the insulin sensitizing agent DRF-2189 in rat plasma.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)